5 beta androstanediol is produced through a metabolic route that does not generate strong androgenic signaling. Higher levels suggest preferential shunting away from DHT formation, which may be protective in tissues sensitive to androgen excess. Lower levels may indicate greater reliance on androgen activating pathways.
5b-Androstanediol is included in these pre-built panels.